Opportunity
DIBBS #SPE2DP-26-T-3370
DLA Solicitation for Moxifloxacin Hydrochloride Tablets (TEVA and RISING PHARMA)
Posted
May 12, 2026
Respond By
May 18, 2026
Identifier
SPE2DP-26-T-3370
NAICS
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain soliciting Moxifloxacin Hydrochloride pharmaceuticals for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - TEVA: Part number NDC00093-7387-56 (7 bottles) - RISING PHARMA: Part number NDC57237-0156-30 (5 bottles) - Additional references to part number 6505015034772 (total 12 bottles across two line items) - Quantities: - 7 bottles (TEVA) - 5 bottles (RISING PHARMA) - Notable Requirements: - Only FDA-approved sources (TEVA and RISING PHARMA) are accepted - Packaging and marking must comply with Medical Marking Standard No. 1A and MIL-STD-129 - Delivery required within 20 days, FOB destination - Compliance with NIST SP 800-171 cybersecurity assessments - Delivery Locations: - USS Sampson DDG 102 (FPO AP 96678) - 0505 EN BN HHC Engineer BN, 2100 Robinwood Road, Gastonia, NC - Contracting Office: - DLA Troop Support Medical Supply Chain, 700 Robbins Avenue, Philadelphia, PA
Description
MOXIFLOXACIN HYDROC (QTY: 7, NSN: 6505-01-503-4772, Purchase Request: 7016724053) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
MOXIFLOXACIN HYDROC (QTY: 5, NSN: 6505-01-503-4772, Purchase Request: 7016740478) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.